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Abstract
Background: The expansion of community pharmacy services is one solution to relieve pressure on general
practice in the United Kingdom (UK). There is a paucity of research of general practitioners’ (GPs’) perspectives of
quality of care in the community pharmacy sector.
The purpose of this study was to explore GPs’:
 Conceptualisation of quality for community pharmacy services, including the management of acute (low
acuity) conditions and defining indispensable aspects of the patient experience (‘always events’)
 Opinions regarding whether and how to measure quality in the community pharmacy sector
Method: Semi-structured interviews were conducted with GPs in the UK. GPs were recruited using the snowballing
technique and professional networks. Interviews were audio-recorded, transcribed and analysed using an
interpretive approach.
Results: Interviews were completed with 20 GPs from Scotland (n = 8) and England (n = 12). Multidimensional and
inter-related concepts of quality were identified; most dimensions related to patient benefit, as well as impact on
GP workload or other health service provision. Interviewees cautioned that “what counts can’t always be measured”.
GPs’ expectations of quality often mirrored those of their own sector, but were ambivalent about the adoption of a
quality outcome framework-type approach. Pharmacist involvement was expected to ensure quality in the
management of ‘acute consultations’, however, GPs lacked awareness of community pharmacy personnel type,
roles and training. Interviewees’ perceptions of quality varied by pharmacy type; independent pharmacies were
sometimes associated with higher quality service delivery than larger chain organisations.
Conclusions: Quality frameworks for community pharmacy services could be partly informed by GP experience and
expectations, but need to be contextual to reflect differences between both settings. The importance of person-
centred care, consistency and continuity was emphasised together with the need for competent personnel and
privacy of interactions.
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Background
Each year in the United Kingdom (UK), an estimated 18
million general practitioner (GP) appointments (~ 13%
of all consultations) are used for conditions suitable for
treatment by community pharmacy personnel, either
with non-prescription medicines and/or advice [1]. The
suitability of community pharmacies for managing these
conditions (hereafter referred to as acute consultations)
is gaining recognition and support from primary care
organisations and through national policies [2–4]. In
England, each community pharmacy serves an average
of 4679 citizens [5, 6], the majority (89%) of whom live
within a 20-min walk of these services [7]. Many patients
prefer to manage acute illness and ailments using self-care
[8] with support from community pharmacy personnel.
The Institute of Medicine’s (IOM’s) six dimensions of
quality suggest health care should be safe, effective, effi-
cient, equitable, timely and person-centred [9]. An emer-
ging approach to exploring and defining healthcare
quality, and one that has also been used in general
practice, is the concept of ‘always events’ [10]. The IHI has
defined these as “aspects of the patient experience that are
so important to patients, their care partners, and service
users that health care providers must aim to perform them
consistently for every individual, every time” [11]. The
quality of care from community pharmacies is variable
[12, 13] and reassurance is needed that the care provided
in this sector is optimised to promote public confidence
and GP support. In turn, GP support could enhance confi-
dence in pharmacy service delivery, general awareness,
and thus utilisation of services – helping to reduce GP
burden [14]. National quality indicators were introduced
for community pharmacy in 2017 and have recently been
updated in the new 5-year Community Pharmacy Con-
tractual Framework [3], but none refer to the management
of acute consultations despite these being regarded as the
“shop window” of community pharmacy [15].
A research programme was undertaken to explore
stakeholders’ perceptions of the quality of community
pharmacy services and the management of acute consul-
tations. Precedent studies have been completed with
members of the public [16] and pharmacy personnel
[15]. The aim of the study reported here was to concep-
tualise GPs’ perceptions and beliefs about the quality of
community pharmacy services in general and, more spe-
cifically, using the concept of ‘always events’ and the
management of acute consultations. It also considered
their attitudes and beliefs about quality measures and in-
dicators for these services.
Methods
Study design
Semi-structured interviews with GPs by telephone or in
person.
Recruitment, sampling and consent
The initial participant was recruited through the researcher’s
(MW) professional network. Thereafter, snowball recruit-
ment was used [17] with each interviewee being asked to
forward an email from the researcher to their GP col-
leagues/professional networks. On receipt of the email, GPs
contacted the researcher if they wished to participate. While
necessarily purposive, the intention was to generate a
maximum variation sample of up to 30 GPs from different
geographical locations (home countries, rural, urban),
personal characteristics (age, gender), and practice charac-
teristics (salaried/non-salaried, group/single-handed). Re-
cruitment ceased once theoretical saturation was reached
(i.e. when no new themes were identified).
Data collection
One female researcher (MW), who is a registered
pharmacist with over 20 years’ post-doctoral experience
of health services research, undertook all data collection.
It is possible that the researcher’s pharmacy background
may have impacted recruitment, i.e. if GPs were reluc-
tant to engage in pharmacy research. Some participants
were known to the researcher; this may have influenced
their contribution. Reflexivity on the part of the lead re-
searcher, and the procedure adopted at the analysis
stage, aimed to mitigate the impact on findings. The in-
terviews were conducted by telephone or face-to-face
between March 2016 and August 2017 and lasted a max-
imum of one hour. The topic guide (Additional file 1)
was informed by existing work on quality and quality
improvement, including the concept of ‘always events’,
as well as the aforementioned interview study involving
pharmacists [11, 15]. During the interview process, the
topic guide was refined with (significant) new themes.
Participants provided verbal and written consent to
participate.
Data handling and analysis
The interviews were audio-recorded and transcribed ver-
batim (by experienced transcribers). Field notes were
made during the interviews. All transcripts were accur-
acy checked (by KS/RW) and anonymised prior to being
analysed with the support of NVivo 11 software. Inter-
viewees were not asked to review the transcripts.
Thematic analysis was undertaken using themes ex-
plored by the topic guide as well with themes derived
from the data [18, 19]. Two researchers (KS, RW), from
outside the pharmacy profession, with considerable ex-
perience of qualitative data analysis, familiarised them-
selves with the transcripts and coded to broad topic
areas (structuring codes). The next (extensive and itera-
tive) phase involved the identification of themes and
sub-themes to reflect the research questions (a priori
codes/nodes) and from within the data itself (in vivo
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codes/nodes). Conceptual and cross-cutting themes were
identified and coded in addition to relevant topic codes.
Each transcript was coded by one researcher, with most
coded by two researchers to ensure reliability. Once coding
was complete, a Framework Approach [20] was used to
support the systematic analysis around the research ques-
tions, to enable an assessment of prevalence and coverage
of key themes (i.e. dimensions of quality). Further interpret-
ation and discussion was undertaken amongst the research
team to ensure that analytical claims were congruent with
the extracts. Participant quotes (anonymised) are presented
to illustrate the themes and are designated E or S to indi-
cate England- and Scotland-based interviewees. The study
is reported to reflect COREQ criteria [21].
Results
Interviews were completed with 20 GPs (Scotland n =
12, England n = 8) and the majority were female (n = 12)
(Table 1). One interview (E11) was conducted face-to-
face and the others were completed by telephone.
Interviewees’ concepts of quality were inter-related
with most dimensions described in relation to patient
benefit, as well as others that related to impact on GPs
and other health services. Their knowledge of pharmacy
services and personnel was frequently gleaned informally
and was often incomplete or inaccurate i.e. most inter-
viewees were unsure of the different types of personnel
and their roles, and generally lacked familiarity with
medicines that were available without a prescription.
Quality concepts of community pharmacy
When asked what a ‘good’ pharmacy looked like, inter-
viewees offered a broad range of characteristics and distin-
guished between different types of pharmacies e.g.
independent versus large chains. They suggested that phar-
macies should be accessible and near to the population that
they serve; and should have extended opening hours (S5)
for the convenience of patients and known to GPs. Patients
should not have to wait “a long time” (S6) for services,
particularly for prescriptions. Most interviewees said that
pharmacies should hold an adequate, well managed stock
(S3, S4) of medication (and alternatives) and other medical
devices, or be able to obtain them quickly. The provision of
a “timely”(S8) service was suggested as a way of reducing
the need for patients to ‘yo-yo’(E10) between the pharmacy
and their general practice and would save GP time by
Table 1 Interviewee Characteristics
ID Country Gender (Male (M)/
Female (F))
Number of years
working as a GP
Status Number
sessions/week
Practice Size No. GPs (~WTEs)
1 Scotland M 20–29 Other 2 11,500 7
2 Scotland M 20–29 Partner 6 8000 7
3 Scotland M 20–29 Senior partner 6 11,500 6
4 Scotland M 10–19 Salaried 6–7 9500 3 (2.25)
5 Scotland F 30+ Other - OOH n/a n/a n/a
6 Scotland F 10–19 Partner 6 3500 2
7 Scotland F 30+ ? 8 + 1 < 2200 1.2
8 Scotland F 0–10 Partner 6 10,000 9 (6.5)
9 England F ? Partner (retired) n/a n/a n/a
10 England F 30+ Partner/Academic 14,700 6 9all p/t + 1 registrar)
11 England M 0–10 Salaried GP/locum/OOH 6 14,500 13 (not all f/t)
12 England M ? Salaried GP/Academic 102 12,000 3 (should have 6)
plus locums
13 England F 10–19 Partner +OOH 7 12,000 7
14 England M ? Principal/Academic 2 11,500 6+
15 England F ? Partner 30,000 10
16 England F 20–29 Partner 6500 4 + 2 assistants
17 England F 30–39 ? 8000 10 (some p/t)
18 England M 20–29 Locum/OOH n/a n/a n/a
19 England F 20–29 Partner 3050 3
20 England F 0–9 Locum/Urgent care
GP General Practitioner Other: category added to protect anonymity of interviewee, OOH Out-of-hours, p/t part-time, f/t full-time, n/a Not applicable, ?
Missing data
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avoiding the need to prescribe substitutions. Home deliver-
ies were considered helpful (S8), although there were some
concerns around safety i.e. due to lack of direct contact be-
tween the patient and pharmacy personnel (E19).
Person-centred care
Interviewees suggested that a good quality pharmacy
would treat patients/customers in much the same way as
other health service providers; pharmacists should be
visible, available, and offer personalised care, with good
listening and communication skills and all staff should
have a positive orientation to patients/customers. They
should involve people in decisions, treat them with sin-
cerity, and always check their understanding of treat-
ment; they should be kind but not “paternalistic” (S8).
S7: It would have a lot of nice people in it who had
enough time to be thorough with their patients, and
be not so overworked and stressed that they then
can't spend time and be nice to them.
Some interviewees distinguished between different
types of pharmacy and perceived better-quality care to
be associated with independent pharmacies, or pharma-
cies where the pharmacist had greater autonomy.
E14: A good quality pharmacy would look like an
independent quite frankly, and it wouldn’t look
like a multiple, and the reason for that is because
it responds to patients’ needs, and it responds to
the needs with [sic] the local GPs as well…
Consistency and continuity of care
Pharmacists should be, and in the experience of
several of the GPs were, familiar with patients (par-
ticularly elderly) and their conditions and therefore
likely to notice health changes, and identify problems
relating to drug efficacy, side effects, and compliance,
which could then be communicated to the GP. There
was an expectation by several GPs that there needed
to be continuity of care, helping to build trust with
patients (and GPs) but with some acknowledgement
that this might be harder to achieve in multiples with
large numbers of staff, in urban areas with numerous
pharmacies, or in rural areas with few.
E20: .. if you have got a pharmacist that knows the
patient well, knows what usually goes in their
Dosette box, is alerted to any changes which might
have occurred, either intentionally or by mistake,
possibly following discharge and they are aware and
they have that insight then it’s really useful, because
they know how things run and they know what
patients are used to.
The need for greater standardisation of practise was also
recognised to provide reassurance to GPs regarding the
quality of care they could expect for their patients.
E18: I thinks it’s very variable because I ..it can be
excellent, particularly where you have situations
where you have got regular, high calibre pharmacists
who can, who you know the level of service that they
are routinely willing to offer. But so often you end up
with, particularly with chains and multiples, where
you have the reliance on agency or part time staff
and therefore the consistency of offering is relatively
low. (…) The reason that we don’t [refer to pharmacies]
is that we never quite know .. which pharmacies are
going to have their A-team on at any given time.
GPs did not report that they wanted to know which
specific person was treating their patients, and this was
not probed.
Quality management of acute consultations
Using the concept of ‘always events’, interviewees were
asked to describe should always and never happen dur-
ing acute consultations (Table 2).
Most interviewees deemed a “proper” acute consultation
to be the same, or similar to a GP-managed consultation:
structured, transparent and adhering to safety protocols and
guidelines, including safeguarding. Some felt that it could be
shorter or more simplified, for example using a pro-forma.
S6: I'm kind of taking it for granted that they've got
some kind of framework for safety and protocols or
guidance that they work within and they should stick
to whatever guidance they're supposed to work within.
History taking (including current conditions), medica-
tions and allergies, was deemed to be essential informa-
tion. The GPs expected pharmacists to ask the “right”
diagnostic questions but not a “barrage”(E15) of ques-
tions, to make an “appropriate” diagnosis (possibly with
an examination), and offer “appropriate” treatment op-
tions, whether medication, self-care, or just reassurance.
E18: ..most [consultations] are benign... there will be
people who will turn up to the pharmacies as the
first point of call … this is the one opportunity to get
somebody really quite important right, and to redirect
them if they are very sick, or to take a step back and
manage things very carefully......... it’s not appropriate for
somebody other than a very experienced pharmacist to
actually conduct that consultation, and it probably
needs to be run more like a proper consultation, knowing
the patient and …taking and recording a more detailed
history, because of the complexity of the patient.
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Pharmacist competence was described in relation to
training and qualifications, experience, broad knowledge
(not limited to medication) and competency in diagno-
sis. Most interviewees assumed that acute consultations
were managed by pharmacists and considered them to
be the most appropriate member of staff to do so. They
were generally unaware of the training that staff, includ-
ing pharmacists, received. Some interviewees expected a
high level of skill in diagnosis, including the ability to
conduct physical examinations. Others were emphatic
that pharmacists are “not diagnosticians” (S6) and should
not be expected to be; that they would not necessarily
have relevant skills, training or experience to diagnose
effectively, especially “undifferentiated” illness, serious or
complex cases. As a minimum, pharmacists were expected
to be aware of “red flags” (E20) and work within their
competencies.
S2: ..a red eye 99 times out of 100 will be conjunctivitis
but it might be acute glaucoma and if you miss that
somebody loses the sight in their eye and that's going
to be a problem. So I think you need your most senior
people dealing with these difficult things.
E11: My experience with pharmacists within
community … is they’ve not got the skill base to
do safe assessments..
E15: .. the pharmacist needs to be trained in
patient-centred skills, .. I think a lot of the people




“introduce yourself, always make it clear who you are, what your
role is, so that there is no misunderstanding with the patient as
to what the limits of your ..experience are” (S2)
Competency –
being aware of own
competency
“it’s about being aware of...recognising your limits of
competence” (E14)
“shouldn’t be done by untrained individuals ...never working
outside your competence” (E11)
Pharmacist
involvement
“it’s not appropriate for someone other than a very experienced
pharmacist to actually conduct that consultation ...and it
probably needs to be run more like a proper consultation” (S5) “I
think it should be done by the pharmacist and not by other staff




“they [the patient] need to be given a minute..to actually tell their
story rather than be asked a lot of direct questions” (S5) “always
take a history” (E16) “making sure that and accurate history is
taken, especially your allergy history” (S4) “getting a history of co-
morbid conditions and concomitant medications” (S1) “self-pre-
scribed medication and GP-prescribed medication” (E9) “the
pharmacist should always have access to notes,,,it’s impossible to
grasp a full history from a few minutes with the patient” (E11)
“jumping straight into prescribing a medication without
understanding the context, particularly in terms of current
medication, pre-existing ill health” (E12) “just selling ...without a
history and without and explanation” (E19) “we never have any
consultation without first of all establishing who the patient is
and getting their background” (E18)
Diagnosis “always listening to the patient and exclusion of..anything more
significant with any particular symptoms” ..(E17)
“never be dismissive of patient’s concerns” (E20)
Safety – Red flags “the pharmacist needs to have the ability and the training and
the knowledge to ask specific questions and exclude any red
flags” (S5) “exclude red flags relating to the condition” (E20)
“ideally not miss a red flag”
Safety –
safeguarding
“anything from an adult protection, vulnerable adults or child
protection, ...follow GMC guidance on ..examining patients” (S8)
Privacy “always have privacy” (S5) “things that pertain to people’s health ....should never be done in
a public place” (S5)
Confidentiality “the confidential nature of the consultation is really important”
(S1) “you’ve got to have confidentiality” (S 3) “there should
always be confidentiality” (S8)
“share information inappropriately” (S3)
Information/advice
provision
“as simple a treatment plan as possible, keep it as simple and
straightforward as possible ..ideally I would want some form of
teach back or checking the patients has understood” (S 1) “get
the right medication; always need to be explained to the patients
exactly what to do” (S 5)
“patients should never be given things without people fully
understanding they fully know how to take them” (S 5) “they
[the patient] should never go away from the pharmacist
..pharmacy..without knowing where to go if things get worse” (S
5)
Commercialism “they’re sold a specific product that is significantly more
expensive than perhaps another product that would do the
same thing” (S4) “unnecessary prescribing expensive medication
that has no benefit (E12)
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coming in will know what they want, ask for a
product and expect it to be a transaction as you
would if you were buying groceries from a shop,
and not expect that barrage of questions. (...) ..
the danger is if community pharmacists ask too
many questions you just end up lying, just to get
something
There was an expectation that pharmacists would refer
patients to a GP or other health care provider if neces-
sary, and “safety-net” by letting the patient know what to
do in the case of no improvement or exacerbation of the
condition. However, there were varying opinions regard-
ing what constitutes an appropriate referral, and GPs’
experiences were mixed. Some felt that pharmacists
referred to them too often and others were concerned
that they might not do so enough.
S6: .. they shouldn’t just be giving people advice just
to get them away out of their doors, or giving them
medicines without having appropriately assessed
them. So if they're pressured for time and they don’t
have the time to deal with the people then either
telling them to come back or not seek other advice
that's not necessarily right, but again if they're
pressured for time it shouldn’t automatically be
oh you'll just have to go to the doctor's surgery
but giving people options of what they can do.
S7: ..they should always have a clear understanding
of their illness and how to deal with it, and how to
manage it in the appropriate fashion. And they
should always leave feeling positive and reassured
about how to do that, rather than feeling more
anxious and uncertain about how to deal with
their own illness.(…)
Several GPs talked about the need for pharmacy services
to be transparent and accountable, through audit or other
mechanisms. There was discussion of the (presumed) ex-
istence of, or need for, formal oversight and accreditation.
E18: So it [a quality consultation] needs to be structured
and transparent enough so you can audit those outcomes
and see that they are broadly comparable, and
the patients are ending up with similar outcomes
to those that they would if they saw a non-
medical prescriber or a GP (…)
E17: ..it would be good if they had a central base,
like Royal College of Pharmacists or something just
to download – ‘this is a specimen policy’ - so they’re
all kind of working to the same thing. I’m sure the
Boots, and the Lloyds and the Superdrugs [sic] all
have centralised things but – and making sure that
their locum pharmacists are all up to date and
qualified.
Privacy, confidentiality and governance
Privacy for acute consultations was considered essential.
Most GPs expected a ‘good’ pharmacy to have at least
one dedicated room, or at least a separate private area,
and to take a “proactive approach” to offering it to
patients/customers. There was a strong feeling that
patients/customers should not have to reveal sensitive
information where it could be overheard, and that pa-
tient confidentiality should be maintained at all times.
Several interviewees had witnessed consultations taking
place over-the -counter and felt this was inappropriate.
S5: .. things that are confidential and things that
pertain to people's health, other than just giving
people simple things for simple problems should
always - should never be done in a public place,
where a lot of other people should hear it. So it
never should be done without privacy.
While interviewees reported being willing to discuss indi-
vidual patients and their treatment with pharmacists, and
for many this was a mark of good communication and a
positive working relationship, there were mixed views
around the recording and sharing patient information. Some
thought it essential for pharmacists to keep records of con-
sultations, and several assumed that they already did so.
S1: When I go in, I'm in some way registered with
the pharmacy so they have some form of identification
system. They have access to my previous information
around over the counter or prescribed medications.
(…) a person who has had an allergy to a particular
substance, they're not getting it again, if they have
access to information such as the repeat prescribing,
or previous prescribing, that they check that every
time.
Whilst some interviewees expected pharmacies to have
access to written medical history, access to patient re-
cords was generally considered to be problematic, both
ethically and practically, especially for GPs who felt that
they had primary responsibility for “their” patients.
E14: (cont.)…and it responds to the needs with the local
GPs as well, who are responsible for the patients’ health,
because that’s where their medical record resides.
Some interviewees cited specific concerns around the
risk of community pharmacists sharing patient informa-
tion with commercial organisations.
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Measuring quality
The majority of interviewees were in general agreement
that quality should be measured to provide “the public
some assurance” (S1). However, defining quality and
“what counts”(E15) was challenging.
E15: .. .. what counts can’t always be measured. So I
think it’s that whole thing of a lady might pick up
her prescriptions every week and the pharmacist she
knows, and smiles and asks her how she is - well
that’s very hard to measure but that may be a
regular conversation she’s having each week.
It was suggested that pharmacies should have a bench-
mark against which to measure themselves, and an
opportunity to learn from good practice elsewhere.
E20: .. if you all have certain objectives that you
need to achieve .. it might make you realise what
other practises and other pharmacists do. ..one thing
that has come out of looking at GPs being regulated
… we weren’t necessarily aware of good practice in
other practices, effective ways of doing things, and we
have learnt a lot through communication and
through working out what’s considered best practice,
how we can then improve.
Many interviewees anticipated disadvantages with
quality measurement. These included increased and/or
divisive competition, perverse incentives and tension
between financial targets and patient care. Several GPs
referred to the “tick box”(E17) approach of the Qualities
and Outcomes Framework for general practices (QOF)
[22] and Care Quality Commission (CQC) [23] inspec-
tions, which they suggested did not adequately address
overall quality of care.
E11: I don’t know what the targets would be
necessarily and typically if you start entering targets
and it becomes a financial incentive and then when
you hear about [large pharmacy chain] doing NMRs
[sic MURs, medication use reviews] on each other ... I
get a bit more sceptical about the use, whether
it’s actually for patient focus and quality or is
this just another measure of working out how
much money do people get.
Methods of quality measurement
Interviewees suggested a range of methods for meas-
uring quality (Table 3). Many made comparisons with
commercial organisations and tools including Trip
Advisor ratings, Amazon customer feedback and food
hygiene ratings.
A few GPs were moderately positive about accredit-
ation and ratings if done in the “right” way.
S1: I'm a big fan of accreditation systems for two
reasons, one the evidence is that it drives up
quality if done in a particular way… And
secondly, it obviously gives the public some
assurance that the professional they're dealing
with has complied with a set of standards. It
gives them some, as I say, assurance rather than
just some reassurance or comfort.
Interviewees were often generally critical of this type
of approach and suggested that pharmacies were differ-
ent from other commercial enterprises, and that services
were variable due to different health needs.
S4: ...if you're talking about a customer-based Trip
Advisor kind of rating then...I would be absolutely
against that much as I am for general practice
because it's just so open to abuse.
Internet-based ratings were thought less accessible to
some patients, unrepresentative and open to manipula-
tion (gaming). There were also concerns about unin-
tended consequences including increased risk aversion
in pharmacies, more siloed working, or pharmacies be-
coming too popular – leading to higher referrals to GPs.
S8: ..the idea of having a pharmacy .... accredited
feels hugely dangerous because .....that becomes very
open and becomes a marketing device. Whereas if it's
the practitioners [i.e. professional assessment], there
is then the accountability of the individual practices
in the face of their professional body to maintain
those skills and competencies.
There was discussion of a service level approach to
accreditation, with ‘core’ services to ensure continuity,
and highlighting of additional services.




Instant feedback devices in pharmacy
In-consultation feedback Customer
satisfaction survey Friends & family
test [28]
External evaluation Metrics and data audit, including outcomes and
safety Comparison with other pharmacies / health
services
Peer assessment Peer support and informal feedback /review 360°
appraisal or “Multi System Feedback” (including
by GPs and other related professions)
Training and self-
assessment
Professional development activities Competency
framework for all pharmacists
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S2: I think it’s better that we raise the consistent
standard rather than you know put pharmacy
against pharmacy.
It was suggested that pharmacists are best-placed to
decide how the quality of their services should be
measured.
E14: ..start with the patient centeredness argument ..get
professionals to reflect upon their own performance
based upon how they’re perceived by their professionals,
and the people they serve - the patients. So that’s
the best starting point. .. ...the only metric or
measurement is around professionalism, which is
autonomy, accountability and responsibility and
that’s what I was talking about with things like
appraisal, 360 feedback etc etc rather than bean




To our knowledge, this is the first exploration of GPs’
perceptions and beliefs specifically regarding the quality
of community pharmacy services in general and the
management of acute consultations in particular. Quality
tended to be considered through the ‘lens’ of general
practice. Multiple dimensions of quality were identified.
The importance of person-centred care, consistency and
continuity was emphasised. The interviewees highlighted
the importance of acute consultations being managed by
competent individuals and with the assurance of privacy
to ensure confidentiality and good governance. There
was general support for the need to measure quality and
the appropriateness of different methods of measurement.
Strengths and limitations
A diverse range of GPs participated in this study and as
such, our results are likely to include and reflect a wide
range of GP opinions and concepts on the topics of
interest. However, as with all qualitative research, our
participant sample was not intended, and cannot be
taken to be, representative of all GPs. The interviewees
engaged well with the ‘always events’ concept. Due to
the recruitment strategies used, a response rate could
not be calculated as the denominator was unknown.
Data collection was undertaken by one experienced
health services researcher (MW) who did not actively
disclose her pharmacist background unless specifically
asked (although correspondence with GPs included her
professional qualifications). The interviewer was known
to several interviewees, either directly (S1, E12) or as a
result of academic affiliations (E14). The wide range of
topics covered indicates that the interviewees shared
positive and negative opinions of community pharmacy
despite the interviewer’s background. We did not specif-
ically assess whether data saturation was achieved, how-
ever, we are confident that theoretical saturation was
achieved as all recurring themes were identified and no
new major themes emerged during the later interviews.
Comparison with existing literature
To our knowledge, this is the first exploration of GPs’
perceptions and beliefs specifically regarding the quality
of community pharmacy services in general and the
management of acute consultations in particular.
Quality tended to be considered through the ‘lens’ of
general practice as well as each GP’s personal experience
of using community pharmacies, rather than professional
interactions. The GPs’ perceptions of quality were often
aligned to those of the public [16], particularly in terms
of relational aspects of consultations and the importance
of privacy.
Contrary to the GPs’ perception, only around one third
of acute consultations involve a pharmacist [24, 25] and
record keeping does not occur routinely. The lack of
documentation for pharmacy services has been cited as a
barrier to the referral of patients by GPs to community
pharmacy services [26]. Low rates of pharmacist involve-
ment could reduce the likelihood of GPs referring patients
for pharmacy management. Earlier research showed
higher rates of guideline compliant outcomes with acute
consultations when pharmacists were involved (driven by
greater information gathering) compared with non-
pharmacist personnel [27]. Whilst GPs in the current
study expected a complete history to be gathered during
acute consultations, they cautioned against a “barrage” of
questions. Pharmacists have identified the ongoing chal-
lenge of providing person-centred care with incomplete
information as well as respective patient autonomy [15].
A recent systematic review concluded that quality-
driven incentives are needed to improve community
pharmacy services in general [28]. Whilst it has been
suggested that service specifications would enhance ser-
vice quality [27], none exist for the management of acute
consultations in this sector. The GPs in this current
study were varied in their support for the introduction
of quality measures for community pharmacy services.
Implications for research and/or practice
Greater collaborative working between GPs and local
community pharmacists could achieve better under-
standing of pharmacy services in general and more
realistic expectations in terms of their delivery, however,
incentives are needed to achieve this goal [28]. The co-
production of service specifications by stakeholders of
community pharmacy services could be undertaken as a
quality improvement initiative in this sector.
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Conclusions
Quality frameworks for community pharmacy services
could be partly informed by GP experience and expecta-
tions, but need to be contextual to reflect differences
between both settings. The importance of person-centred
care, consistency and continuity was emphasised together
with the need for competent personnel and privacy of
interactions.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12875-020-01319-2.
Additional file 1. Topic Guide.
Additional file 2. Additional Illustrative Quotes.
Abbreviations
COREQ: Consolidated criteria for reporting qualitative research; CQC: Care
Quality Commission; f/t : Full time; GMC: General Medical Council;
GP: General Practitioner; Id: Identification; IOM: Institute of Medicine; n/a: Not
applicable; OOH: Out of hours; p/t: Part time; QOF: Quality Outcomes
Framework; UK: United Kingdom
Acknowledgements
We thank all the general practitioners who participated in interviews.
Authors’ contributions
MW was responsible for funding acquisition, led the conceptualisation of the
work, undertook all data acquisition, supervised and contributed to the
formal analysis and interpretation of the data, drafted the work and revised it
critically for important intellectual content. KS advised on and developed
analytical tools and frameworks, and contributed towards data analysis and
interpretation, manuscript production and revisions. RW contributed towards
formal analysis and interpretation, manuscript production and revisions. The
authors read and approved the final manuscript.
Funding
This work was supported by a Health Foundation Improvement Science
Fellowship awarded to Professor M C Watson (no reference number).
Availability of data and materials
The data collected for this study have not been made available for sharing
because consent for sharing was not requested from participants and
resources are not available to de-identify the dataset.
Ethics approval and consent to participate
The University of Aberdeen College Ethics Review Board, NHS Research and
Development (Scotland) (CERB/2015/6/1208) and the Health Regulatory
Authority (England) provided ethical review and approval for the study (IRAS
197913).






1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of
Strathclyde, Robertson Wing 601H, 161 Cathedral Street, Glasgow G40RE, Scotland.
2Department for Health, University of Bath, Bath, England BA2 7AY, UK.
Received: 18 June 2020 Accepted: 15 November 2020
References
1. Fielding S, Porteous T, Ferguson J, et al. Estimating the burden of minor
ailment consultations in general practices and emergency departments
through retrospective review of routine data in north East Scotland. Fam
Pract. 2015;32(2):165–72.
2. Clay H, Stern R. Making time in general practice: freeing GP capacity by
reducing bureaucracy and avoidable consultations, managing the interface
with hospitals and exploring new ways of working. Primary Care
Foundation/NHS Alliance; 2015 Available online at http://www.nhsalliance.
org/wp-content/uploads/2015/10/Making-Time-in-General-Practice-FULL-
REPORT-01-10-15.pdf [Accessed 22 March 2020].
3. Department of Health and Social Care, the NHS England and NHS
Improvement and Pharmaceutical Services Negotiating Committee. The
Community Pharmacy Contractual Framework for 2019/20 to 2023/24:
supporting delivery for the NHS Long Term Plan. Department of Health
and Social Care; 2019 Available online at https://assets.publishing.
service.gov.uk/government/uploads/system/uploads/attachment_data/
file/819601/cpcf-2019-to-2024.pdf [Accessed 22 March 2020].
4. NHS England. Transforming urgent and emergency care services in England.
Urgent and emergency care review end of phase 1 report. Appendix 1—Revised
evidence base from the urgent and emergency care review. The Urgent and
Emergency Care Review. NHS, London; 2013.
5. UK Population. England Population 2020. Available at https://www.
ukpopulation.org/england-population/ [Accessed 22 March 2020].
6. Statista. Number of community pharmacies in England from 2006/07 to 2018/
19. Available online at https://www.statista.com/statistics/418071/
community-pharmacies-in-england/ [Accessed 22 March 2020].
7. Todd A, Copeland A, Husband A, et al. The positive pharmacy care law: an
area-level analysis of the relationship between community pharmacy
distribution, urbanity and social deprivation in England. BMJ Open. 2014;
4(8):e005764.
8. Porteous T, Ryan M, Bond CM, Hannaford P. Preferences for self-care or
professional advice for minor illness: a discrete choice experiment. Br J Gen
Pract. 2006;56(533):911–7.
9. Institute of Medicine. Crossing the quality chasm: a new health system for
the 21st century. Washington: National Academy Press; 2001.
10. Bowie P, McNab D, Ferguson J, et al. Quality improvement and person-
centredness: A participatory mixed methods study to develop the ‘always
event’ concept for primary care. BMJ Open. 2015;5(4).
11. Institute for Healthcare Improvement. Always events toolkit. Available online
at http://www.ihi.org/resources/Pages/Tools/Always-Events-Toolkit.aspx
[Accessed 22 March 2020].
12. Studman A. Three in 10 pharmacies not following safety guidelines, finds
Which? Investigation. Which?; 2018 Available online at https://www.which.
co.uk/news/2018/02/three-in-10-pharmacies-not-following-safety-guidelines-
finds-which-investigation/ [Accessed 22 March 2020].
13. Inch J, Porteous T, Maskrey V, et al. It's not what you do it's the way that it's
measured: quality assessment of minor ailment management in community
pharmacies. Int J Pharm Pract. 2017;25(4):253–62.
14. Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P.
How to enhance public health service utilization in community pharmacy?:
general public and health providers' perspectives. Res Soc Adm Pharm.
2014;10(2):272–84.
15. Watson MC, Skea ZC. Jugglers and tightrope walkers: The challenge
of delivering quality community pharmacy services. PLoS One. 2018;
13(7).
16. Watson MC, Silver K, Watkins R. How does the public conceptualise the
quality of care and its measurement in community pharmacies in the UK: a
qualitative interview study. BMJ Open. 2019;9(3):e027198.
17. Bowling A. Research methods in health: investigating health and health
services. McGraw-hill education (UK); 2014.
18. Attride-Stirling J. Thematic networks: an analytic tool for qualitative research.
Qual Res. 2001;1(3):385–405.
19. Braun V, Clarke V. Successful qualitative research: a practical guide for
beginners. Sage; 2013.
20. Ritchie J, Spencer L, O’Connor W. Carrying out qualitative analysis. Qual Res
Pract. 2003:219–62.
Watson et al. BMC Family Practice          (2020) 21:244 Page 9 of 10
21. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative
research (COREQ): a 32-item checklist for interviews and focus groups. Int J
Qual Health C. 2007;19(6):349–57.
22. NHS Digital. Quality Outcomes Framework (QOF)Disease prevalence and




23. Care Quality Commission. When we will inspect GP practices; 2019 Available
online at https://www.cqc.org.uk/guidance-providers/gps/when-we-will-
inspect-gp-practices [Accessed 02 April 2020].
24. NHS. Friends and Family Test (FFT); 2020 Available online at https://
www.nhs.uk/using-the-nhs/about-the-nhs/friends-and-family-test-fft/
[Access 02 April 2020].
25. Watson MC, Bond CM, Grimshaw JM, et al. Educational strategies to
promote evidence-based community pharmacy practice: a cluster
randomized controlled trial (RCT). Fam Pract. 2002;19(5):529–36.
26. Hindi AM, Schafheutle EI, Jacobs S. Community pharmacy integration within
the primary care pathway for people with long-term conditions: a focus
group study of patients’, pharmacists’ and GPs’ experiences and
expectations. BMC Fam Pract. 2019;20(1):26.
27. Watson MC, Bond CM, Grimshaw JM, Johnston M. Factors predicting the
guideline compliant supply (or non-supply) of nonprescription medicines in
the community pharmacy setting. Qual Saf Health Care. 2006;15:53–7.
28. Hindi AM, Jacobs S, Schafheutle EI. Solidarity or dissonance? A systematic
review of pharmacist and GP views on community pharmacy services in the
UK. Health Soc Care Community. 2019;27(3):565–98.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Watson et al. BMC Family Practice          (2020) 21:244 Page 10 of 10
